Category: Letter From the Editor
Letter From the Editor: Exploring Cardiovascular Comorbidities and Inflammatory Bowel Disease
Heart disease has been the number one cause of death in the United States for more than a century, according to the Centers for Disease Control […]
Letter From the Editor: Applications of Artificial Intelligence in Esophageal Diseases
Can artificial intelligence (AI) improve our management of esophageal diseases? This month’s issue of Gastroenterology & Hepatology explores the potential use of AI in patients with […]
Letter From the Editor: Exploring Vaccination in Patients With Inflammatory Bowel Disease
Vaccination has become a polarizing issue in the United States, as Dr Francis A. Farraye notes in this month’s issue of Gastroenterology & Hepatology. Two of […]
Letter From the Editor: Marking Our Twentieth Year of Covering Gastroenterology and Hepatology
The journal Gastroenterology & Hepatology marks the beginning of its twentieth year of publication with a wide variety of informative and clinically relevant articles. Among the […]
Letter From the Editor: Examining Janus Kinase Inhibitors for the Treatment of Inflammatory Bowel Disease
How different are drugs in the same class? A review article in this month’s issue of Gastroenterology & Hepatology explores this question in a comprehensive overview […]
Letter From the Editor: Spotlight on Hepatology
In anticipation of the upcoming Liver Meeting, being held in Boston, Massachusetts in November, this month’s issue of Gastroenterology & Hepatology shines a spotlight on hepatology. […]
Letter From the Editor: Managing Older Patients Who Have Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) was often considered a disease of the young in the past. However, with a recent epidemiologic shift, older adults now comprise the […]
Letter From the Editor: Shifting Our Focus From NASH to MASH
This month’s issue of Gastroenterology & Hepatology features our newly titled MASH in Focus column, formerly NASH in Focus. This name change reflects the new liver […]
Letter From the Editor: Small Molecule and Biologic Therapies for Ulcerative Colitis
Currently, there are a number of different small molecule and biologic therapies approved by the US Food and Drug Administration (FDA) for the treatment of patients […]
Nonalcoholic Steatohepatitis Drug Development
Worldwide, the most common cause of chronic liver disease is now nonalcoholic fatty liver disease, which affects a quarter of the population. This disease is a […]
Letter From the Editor: Exploring Clostridioides difficile Infection and Microbiome Therapeutics
Clostridioides difficile continues to be a public health concern in the United States, where the Centers for Disease Control and Prevention designated it to be an […]
Letter From the Editor: Examining Race and Ethnicity in Patients With Inflammatory Bowel Disease
As Dr Marie L. Borum recounts in this month’s issue of Gastroenterology & Hepatology, it was frequently taught in the past that Black and Hispanic individuals […]
Letter From the Editor: Green Endoscopy and Sustainable Care
Sustainability is becoming an important concept in medical care, particularly in endoscopy. This month’s issue of Gastroenterology & Hepatology highlights this meaningful and timely topic in […]
Letter From the Editor: Breath Testing for Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth
Breath testing is the most common method currently being used for diagnosing small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO). One of the review […]
Letter From the Editor: Virtual Reality and Disorders of Gut-Brain Interaction
Is virtual reality the next frontier in the treatment of patients with disorders of gut-brain interaction (DGBIs)? A review article in this month’s issue of Gastroenterology […]
Letter From the Editor: Liver Transplant in Patients With Obesity
It is well known that obesity is a significant public health issue both worldwide and in the United States. According to global estimates from the World […]
Letter From the Editor: Exploring the Utility of Potassium-Competitive Acid Blockers in Acid Peptic Disorders
Do potassium-competitive acid blockers have a role to play in the management of patients with acid peptic disorders? This question is explored in a review article […]
Letter From the Editor: Rapid Initiation of Hepatitis C Virus Treatment
We are currently fortunate to have safe and efficient therapy for the treatment of patients with hepatitis C virus (HCV) infection. In clinical practice, a frequently […]
Letter From the Editor: Emerging Treatments for Inflammatory Bowel Disease
Which therapies look promising as future therapeutic options for the treatment of patients with inflammatory bowel disease (IBD)? A review article in this month’s issue of […]
Letter From the Editor: Spotlight on COVID-19
Over the past several years, COVID-19 has had an enormous impact on our lives. This month’s issue of Gastroenterology & Hepatology features two timely and interesting […]